Epilepsy surgery: an effective but underutilized treatment worldwide

Authors

DOI:

https://doi.org/10.59594/iicqp.2026.v4n1.169

Abstract

To the Editor,

Epilepsy surgery continues to be an underutilized treatment worldwide, particularly in our country, despite findings from controlled clinical trials and more than 100 case series and observational studies supporting the efficacy and safety of resective surgery and, more recently, non-resective surgical interventions for the treatment of adults and children with drug-resistant epilepsy (DRE) (1). Moreover, this intervention is not only effective in controlling seizures, but also in improving psychosocial aspects, functioning, and autonomy, reducing medication burden, and increasing overall patient satisfaction. Most complications following epilepsy surgery are mild or transient (e.g., intracranial or extracranial infections) and usually resolve completely. Severe and permanent neurological complications (such as aphasia or hemianopsia) are infrequent, and surgery-related mortality is extremely rare (1).

Downloads

Download data is not yet available.

References

Jetté N, Sander JW, Keezer MR. Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol. 2016;15(9):982-94. doi: 10.1016/S1474-4422(16)30127-2

GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(4):357-75. doi: 10.1016/S1474-4422(18)30454-X

Alva-Díaz C, Navarro-Flores A, Rivera-Torrejon O, Huerta-Rosario A, Molina RA, Velásquez-Rimachi V, et al. Prevalence and incidence of epilepsy in Latin America and the Caribbean: A systematic review and meta-analysis of population-based studies. Epilepsia. 2021;62(4):984-96. doi: 10.1111/epi.16850

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-77. doi: 10.1111/j.1528-1167.2009.02397.x

Perucca E, Perucca P, White HS, Wirrell EC. Drug resistance in epilepsy. Lancet Neurol. 2023;22(8):723-34. doi: 10.1016/S1474-4422(23)00151-5

Okubo Y, Fallah A, Hayakawa I, Handa A, Nariai H. Trends in hospitalization and readmission for pediatric epilepsy and underutilization of epilepsy surgery in the United States. Seizure. 2020;80:263-9. doi: 10.1016/j.seizure.2020.05.013

Jehi L, Jette N, Kwon CS, Josephson CB, Burneo JG, Cendes F, et al. Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia. 2022;63(10):2491-506. doi: 10.1111/epi.17350

Wiebe S. Epilepsy: Does access to care influence the use of epilepsy surgery? Nat Rev Neurol. 2016;12(3):133-4. doi: 10.1038/nrneurol.2016.7

Engel J Jr. Overview of surgical treatment for epilepsy. En: Shorvon S, Perucca E, Engel J Jr, editores. The Treatment of Epilepsy. 4.ª ed. London: Wiley-Blackwell; 2015. p. 709-22.

Cross JH, Reilly C, Gutierrez Delicado E, Smith ML, Malmgren K. Epilepsy surgery for children and adolescents: evidence-based but underused. Lancet Child Adolesc Health. 2022;6(7):484-94. doi: 10.1016/S2352-4642(22)00098-0

Published

2026-04-16

Issue

Section

Letter to the editor

How to Cite

1.
De la Cruz Ramírez W. Epilepsy surgery: an effective but underutilized treatment worldwide. Investig. innov. clín. quir. pediátr. [Internet]. 2026 Apr. 16 [cited 2026 Jun. 1];4(1):78-80. Available from: https://investigacionpediatrica.insnsb.gob.pe/index.php/iicqp/article/view/169